Comparative Analysis of Human Mesenchymal Stem Cells Derived from Bone Marrow, Placenta, and Adipose Tissue as Sources of Cell Therapy

Journal of Cellular Biochemistry

Volumn 117, Issue 5, 2016, Pages 1112-1125

  Jeon, Young Joo ^a   Kim, Jumi ^b   Cho, Jin Hyoung ^a   Chung, Hyung Min ^c   Chae, Jung Il ^a  

^a Chonbuk National University   (South Korea)

^b Samsung Advanced Institute of Technology (SAIT)   (South Korea)

^c Konkuk University School of Medicine   (South Korea)

Author keywords

ADIPOSE TISSUE; BONE MARROW; MSC; PLACENTA; PROTEOMICS

Indexed keywords

MEMBRANE ANTIGEN; PEROXIREDOXIN; PROTEOME;

ADIPOSE TISSUE; ANTIGEN EXPRESSION; ARTICLE; BLOOD FLOW; BONE MARROW; CELL DIFFERENTIATION; CELL THERAPY; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOSKELETON; DOWN REGULATION; FEMALE; HUMAN; HUMAN CELL CULTURE; HUMAN TISSUE; ISCHEMIA; MESENCHYMAL STEM CELL; MOUSE; NONHUMAN; OXIDATIVE STRESS; PHENOTYPE; PLACENTA; PRIORITY JOURNAL; PROTEIN ANALYSIS; REGULATORY MECHANISM; ADIPOGENESIS; ANIMAL; BIOLOGICAL THERAPY; BONE DEVELOPMENT; BONE MARROW CELL; CELL CULTURE; CHONDROGENESIS; CYTOLOGY; HINDLIMB; LIQUID CHROMATOGRAPHY; MESENCHYMAL STROMA CELL; METABOLISM; NUDE MOUSE; PREGNANCY; PROCEDURES; PROTEOMICS; TANDEM MASS SPECTROMETRY; TWO DIMENSIONAL GEL ELECTROPHORESIS; VASCULARIZATION; WESTERN BLOTTING;

ADIPOGENESIS; ADIPOSE TISSUE; ANIMALS; BLOTTING, WESTERN; BONE MARROW CELLS; CELL DIFFERENTIATION; CELL- AND TISSUE-BASED THERAPY; CELLS, CULTURED; CHONDROGENESIS; CHROMATOGRAPHY, LIQUID; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FEMALE; HINDLIMB; HUMANS; ISCHEMIA; MESENCHYMAL STROMAL CELLS; MICE, NUDE; OSTEOGENESIS; PLACENTA; PREGNANCY; PROTEOME; PROTEOMICS; TANDEM MASS SPECTROMETRY;

EID: 84960127802     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.25395     Document Type: Article

References (48)

1. Arien-Zakay H, Lecht S, Bercu MM, Tabakman R, Kohen R, Galski H, Nagler A, Lazarovici P,. 2009. Neuroprotection by cord blood neural progenitors involves antioxidants, neurotrophic and angiogenic factors. Exp Neurol 216: 83-94.
2. Barry F, Boynton R, Murphy M, Haynesworth S, Zaia J,. 2001. The SH-3 and SH-4 antibodies recognize distinct epitopes on CD73 from human mesenchymal stem cells. Biochem Biophys Res Commun 289: 519-524.
3. Barry FP, Boynton RE, Haynesworth S, Murphy JM, Zaia J,. 1999. The monoclonal antibody SH-2, raised against human mesenchymal stem cells, recognizes an epitope on endoglin (CD105). Biochem Biophys Res Commun 265: 134-139.
4. Calio ML, Marinho DS, Ko GM, Ribeiro RR, Carbonel AF, Oyama LM, Ormanji M, Guirao TP, Calio PL, Reis LA, Simoes Mde J, Lisboa-Nascimento T, Ferreira AT, Bertoncini CR,. 2014. Transplantation of bone marrow mesenchymal stem cells decreases oxidative stress, apoptosis, and hippocampal damage in brain of a spontaneous stroke model. Free Radic Biol Med 70: 141-154.
5. Caplan AI,. 1991. Mesenchymal stem cells. J Orthop Res 9: 641-650.
6. Caplan AI,. 2007. Adult mesenchymal stem cells for tissue engineering versus regenerative medicine. J Cell Physiol 213: 341-347.
7. Chae JI, Kim DW, Lee N, Jeon YJ, Jeon I, Kwon J, Kim J, Soh Y, Lee DS, Seo KS, Choi NJ, Park BC, Kang SH, Ryu J, Oh SH, Shin DA, Lee DR, Do JT, Park IH, Daley GQ, Song J,. 2012. Quantitative proteomic analysis of induced pluripotent stem cells derived from a human Huntington's disease patient. Biochem J 446: 359-371.
8. Ciuffreda L, Falcone I, Incani UC, Del Curatolo A, Conciatori F, Matteoni S, Vari S, Vaccaro V, Cognetti F, Milella M,. 2014. PTEN expression and function in adult cancer stem cells and prospects for therapeutic targeting. Adv Biol Regul 56: 66-80.
9. Couffinhal T, Silver M, Kearney M, Sullivan A, Witzenbichler B, Magner M, Annex B, Peters K, Isner JM,. 1999. Impaired collateral vessel development associated with reduced expression of vascular endothelial growth factor in ApoE-/- mice. Circulation 99: 3188-3198.
10. De Ugarte DA, Morizono K, Elbarbary A, Alfonso Z, Zuk PA, Zhu M, Dragoo JL, Ashjian P, Thomas B, Benhaim P, Chen I, Fraser J, Hedrick MH,. 2003. Comparison of multi-lineage cells from human adipose tissue and bone marrow. Cells Tissues Organs 174: 101-109.
11. Dorritie KA, Redner RL, Johnson DE,. 2014. STAT transcription factors in normal and cancer stem cells. Adv Biol Regul 56: 30-44.
12. Eckle T, Fullbier L, Wehrmann M, Khoury J, Mittelbronn M, Ibla J, Rosenberger P, Eltzschig HK,. 2007. Identification of ectonucleotidases CD39 and CD73 in innate protection during acute lung injury. J Immunol 178: 8127-8137.
13. Erices A, Conget P, Minguell JJ,. 2000. Mesenchymal progenitor cells in human umbilical cord blood. Br J Haematol 109: 235-242.
14. Fitzgerald TL, McCubrey JA,. 2014. Pancreatic cancer stem cells: Association with cell surface markers, prognosis, resistance, metastasis and treatment. Adv Biol Regul 56: 45-50.
15. Friedenstein AJ, Chailakhyan RK, Latsinik NV, Panasyuk AF, Keiliss-Borok IV,. 1974a. Stromal cells responsible for transferring the microenvironment of the hemopoietic tissues. Cloning in vitro and retransplantation in vivo. Transplantation 17: 331-340.
16. Friedenstein AJ, Deriglasova UF, Kulagina NN, Panasuk AF, Rudakowa SF, Luria EA, Ruadkow IA,. 1974b. Precursors for fibroblasts in different populations of hematopoietic cells as detected by the in vitro colony assay method. Exp Hematol 2: 83-92.
17. Giuffre M, Rizzo M, Scaturro G, Pitruzzella A, Gammazza AM, Cappello F, Corsello G, Li Volti G,. 2015. Oxidative stress markers at birth: Analyses of a neonatal population. Acta Histochem 117: 486-491.
18. Gregory CA, Prockop DJ, Spees JL,. 2005. Non-hematopoietic bone marrow stem cells: Molecular control of expansion and differentiation. Exp Cell Res 306: 330-335.
19. Haeryfar SM, Hoskin DW,. 2004. Thy-1: More than a mouse pan-T cell marker. J Immunol 173: 3581-3588.
20. Hordijk P,. 2003. Endothelial signaling in leukocyte transmigration. Cell Biochem Biophys 38: 305-322.
21. Huang J, Xie LD, Luo L, Zheng SL, Wang HJ, Xu CS,. 2014. Silencing heat shock protein 27 (HSP27) inhibits the proliferation and migration of vascular smooth muscle cells in vitro. Mol Cell Biochem 390: 115-121.
22. Jiang Y, Jahagirdar BN, Reinhardt RL, Schwartz RE, Keene CD, Ortiz-Gonzalez XR, Reyes M, Lenvik T, Lund T, Blackstad M, Du J, Aldrich S, Lisberg A, Low WC, Largaespada DA, Verfaillie CM,. 2002. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 418: 41-49.
23. Kern S, Eichler H, Stoeve J, Kluter H, Bieback K,. 2006. Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. Stem Cells 24: 1294-1301.
24. Kopen GC, Prockop DJ, Phinney DG,. 1999. Marrow stromal cells migrate throughout forebrain and cerebellum, and they differentiate into astrocytes after injection into neonatal mouse brains. Proc Natl Acad Sci USA 96: 10711-10716.
25. Kuhbier JW, Weyand B, Radtke C, Vogt PM, Kasper C, Reimers K,. 2010. Isolation, characterization, differentiation, and application of adipose-derived stem cells. Adv Biochem Eng Biotechnol 123: 55-105.
26. Li G, Zhang XA, Wang H, Wang X, Meng CL, Chan CY, Yew DT, Tsang KS, Li K, Tsai SN, Ngai SM, Han ZC, Lin MC, He ML, Kung HF,. 2009. Comparative proteomic analysis of mesenchymal stem cells derived from human bone marrow, umbilical cord, and placenta: Implication in the migration. Proteomics 9: 20-30.
27. Liu D, Hui H, Chai X, Wang B, Qiu J,. 2010. Construction of tissue-engineered cartilage using human placenta-derived stem cells. Sci China Life Sci 53: 207-214.
28. Lu FZ, Fujino M, Kitazawa Y, Uyama T, Hara Y, Funeshima N, Jiang JY, Umezawa A, Li XK,. 2005. Characterization and gene transfer in mesenchymal stem cells derived from human umbilical-cord blood. J Lab Clin Med 146: 271-278.
29. McCubrey JA, Davis NM, Abrams SL, Montalto G, Cervello M, Libra M, Nicoletti F, D'Assoro AB, Cocco L, Martelli AM, Steelman LS,. 2014. Targeting breast cancer initiating cells: Advances in breast cancer research and therapy. Adv Biol Regul 56: 81-107.
30. Mege RM, Gavard J, Lambert M,. 2006. Regulation of cell-cell junctions by the cytoskeleton. Curr Opin Cell Biol 18: 541-548.
31. Musina RA, Bekchanova ES, Belyavskii AV, Sukhikh GT,. 2006. Differentiation potential of mesenchymal stem cells of different origin. Bull Exp Biol Med 141: 147-151.
32. Nourshargh S, Marelli-Berg FM,. 2005. Transmigration through venular walls: A key regulator of leukocyte phenotype and function. Trends Immunol 26: 157-165.
33. Ode A, Kopf J, Kurtz A, Schmidt-Bleek K, Schrade P, Kolar P, Buttgereit F, Lehmann K, Hutmacher DW, Duda GN, Kasper G,. 2011. CD73 and CD29 concurrently mediate the mechanically induced decrease of migratory capacity of mesenchymal stromal cells. Eur Cell Mater 22: 26-42.
34. Panepucci RA, Siufi JL, Silva WA, Jr., Proto-Siquiera R, Neder L, Orellana M, Rocha V, Covas DT, Zago MA,. 2004. Comparison of gene expression of umbilical cord vein and bone marrow-derived mesenchymal stem cells. Stem Cells 22: 1263-1278.
35. Parker AM, Katz AJ,. 2006. Adipose-derived stem cells for the regeneration of damaged tissues. Expert Opin Biol Ther 6: 567-578.
36. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S, Marshak DR,. 1999. Multilineage potential of adult human mesenchymal stem cells. Science 284: 143-147.
37. Poljsak B, Suput D, Milisav I,. 2013. Achieving the balance between ROS and antioxidants: When to use the synthetic antioxidants. Oxid Med Cell Longev 2013: 956792.
38. Rajan S, Ahmed RP, Jagatheesan G, Petrashevskaya N, Boivin GP, Urboniene D, Arteaga GM, Wolska BM, Solaro RJ, Liggett SB, Wieczorek DF,. 2007. Dilated cardiomyopathy mutant tropomyosin mice develop cardiac dysfunction with significantly decreased fractional shortening and myofilament calcium sensitivity. Circ Res 101: 205-214.
39. Ray PD, Huang BW, Tsuji Y,. 2012. Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling. Cell Signal 24: 981-990.
40. Saalbach A, Haustein UF, Anderegg U,. 2000. A ligand of human thy-1 is localized on polymorphonuclear leukocytes and monocytes and mediates the binding to activated thy-1-positive microvascular endothelial cells and fibroblasts. J Invest Dermatol 115: 882-888.
41. Sakaguchi Y, Sekiya I, Yagishita K, Muneta T,. 2005. Comparison of human stem cells derived from various mesenchymal tissues: Superiority of synovium as a cell source. Arthritis Rheum 52: 2521-2529.
42. Singer NG, Caplan AI,. 2011. Mesenchymal stem cells: Mechanisms of inflammation. Annu Rev Pathol 6: 457-478.
43. Sung JH, Yang HM, Park JB, Choi GS, Joh JW, Kwon CH, Chun JM, Lee SK, Kim SJ,. 2008. Isolation and characterization of mouse mesenchymal stem cells. Transplant Proc 40: 2649-2654.
44. Toole BP,. 2009. Hyaluronan-CD44 Interactions in Cancer: Paradoxes and Possibilities. Clin Cancer Res 15: 7462-7468.
45. Tosaki A, Edes I,. 2006. The role of peroxiredoxins in ischemia-reperfusion-induced cardiac damage. Am J Physiol Heart Circ Physiol 291: H2586-H2587.
46. Wakitani S, Saito T, Caplan AI,. 1995. Myogenic cells derived from rat bone marrow mesenchymal stem cells exposed to 5-azacytidine. Muscle Nerve 18: 1417-1426.
47. Williams AF, Gagnon J,. 1982. Neuronal cell Thy-1 glycoprotein: Homology with immunoglobulin. Science 216: 696-703.
48. Young RG, Butler DL, Weber W, Caplan AI, Gordon SL, Fink DJ,. 1998. Use of mesenchymal stem cells in a collagen matrix for Achilles tendon repair. J Orthop Res 16: 406-413.